In Saccharomyces cerevisiae, mutations in FKSJ confer hypersensitivity to the immunosuppressants FK506 and cyclosporin A, while mutations in ETGI confer resistance to the cell-wall-active echinocandins (inhibitors of 1,3-J3D-glucan synthase) and, in some cases, concomitant hypersensitivity to the chitin synthase inhibitor nikkomycin Z.
The cell wall of yeast and filamentous fungi is essential for their shape and viability. Among the structural elements of the wall are the polysaccharides 1,3-,-D-glucan and chitin (1) . The biosynthetic pathways of these molecules are important targets for the development of fungicidal agents (2, 3).
1,3-3-D-Glucan synthase (UDPglucose: 1,3-,3D-glucan 3-/3 D-glucosyltransferase; EC 2.4.1.34) is a membrane enzyme activated by GTP which has been fractionated into soluble (GTP-binding) and membrane-bound (catalytic) components (4) . Members of the echinocandin family of antifungal antibiotics inhibit 1,3-,B3D-glucan synthase (2, 3) and are potentially useful for the isolation of genes encoding subunits of this enzyme by way of resistance mutations. Unfortunately, the potency of most echinocandins against Saccharomyces cerevisiae is too low to be useful for this purpose (5) . Recently, however, we have used L-733,560, a novel echinocandin which is highly effective against S. cerevisiae, to isolate resistant (EchR) mutants with resistant glucan synthase activity (6, 7) . Drug resistance of the enzyme from one of the mutants (etgl-l) fractionates with the membranebound component (6) , whereas another mutation (etgl-4) results in concomitant hypersensitivity of cells to the chitin synthase inhibitor nikkomycin Z (Niks) (7) . We undertook the cloning of the wild-type gene (ETGI) by complementation of these alleles and anticipated that ETGI would encode a subunit of 1,3-,-D-glucan synthase.
The immunosuppressants FK506 and cyclosporin A (CsA) also have antifungal activity. Although vegetative growth of yeast is not potently inhibited by these drugs, recovery from mating factor arrest is (8) . The drugs inhibit yeast recovery and T-cell activation by similar mechanisms. Each binds to an intracellular receptor (FKBP12 for FK506 and cyclophilin for CsA), and the receptor-drug complex inhibits the Ca2+/ calmodulin-dependent protein phosphatase calcineurin (9, 10) . We previously described a mutation (Jksl-l) which results in calcineurin-dependent growth and hypersensitivity to FK506 (FKs) and CsA (11) . We cloned the hypersensitivity locus (FKSJ) to help identify targets of calcineurin.t To our surprise FKS1 and ETGI are identical.:
MATERIALS AND METHODS Microbiological Methods and Strains. YPAD and drop-out (DO) media and procedures for mating, sporulation, tetrad analysis, transformation, gene disruption, and determination of antibiotic sensitivity have been described (6, 12) . Meiotic progeny of diploid YFK016 (12) were mated to produce the yeast a/a diploid YFK419 (homozygous for ade2-101 his3-A200 leu2-Al lys2-801 trpl-Al, and ura3-52). R560-1C (MATa ade2-1 canl his3-11,15 leu2-3,112 trpl-l ura3-1 etgl-l) and MS14 (MATa etgl4) are spontaneous L-733,560-resistant (EchR) mutants derived from W303-1A (6) and X2180-1A (7), respectively. EchR mutants are resistant to drug on uracil DO medium at 8 ,g/ml, whereas the wild type is sensitive at 0. 25 ,ug/ml. Heterozygous (etgl-l/+) strains exhibited intermediate resistance (Echl phenotype) and were resistant at 1 pg/ml but sensitive at 4 ug/ml.
Cloning. A plasmid (pFF119) complementing Jksl-l was selected from a yeast genomic library of strain GRF88 (13) on uracil DO medium containing FK506 at 1 pg/ml. A library of genomic DNA (provided by S. Parent) from strain YFK093 (12) was constructed as described (14) by partial Sau3A1 digestion, partial fill-in of overhangs, and insertion of the fragments into the partially filled-in Sal I site of plasmid YEp24 tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. U12893).
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prototrophs were selected, and clones with partial reversal of EchR were identified by their failure to grow when replicated onto selective medium containing L-733,560 at 4 ,ug/ml. A plasmid (pMS14) complementing etgl4 was selected from the GRF88 library on uracil DO medium containing nikkomycin Z (Calbiochem) at 75 ,g/ml. Chromosomal locations of cloned DNA were established by hybridization of a Chromo-Blot (Clontech) of S. cerevisiae strain YPH80.
Nucleotide Sequence Analysis. The sequences ofboth strands of DNA were determined with Sequenase version 2.0 (United States Biochemical) or by Taq cycle sequencing on a model 373A automated DNA sequencer (Applied Biosystems), and sequence analysis was performed with the computer programs provided by the Genetics Computer Group (15) .
Glucan Synthase Assay. Particulate membrane fractions were prepared from cells grown to an OD600 of 0.8 in 150 ml of YPAD; collected by centrifugation (0.5 g of cell wet weight); resuspended to 1.5 ml with buffer containing 50 mM sodium phosphate (pH 7. (11) . A plasmid (pFF119) containing an insert of -15 kb was isolated. An 11-kb Sph I fragment which complemented the mutation was transferred to YCplac33 (17) in both orientations, giving plasmids pFF133 and pFF135 (Fig. 1A) . Nested subclones were created by complete digestion with BamHI and partial digestion with Sau3A1 (18) , and the complementing DNA was further localized to a 6.0-to 7.8-kb region (Fig. 1A) .
To initiate a genetic analysis, a deletion/disruption of the cloned DNA was constructed in vitro. The 8.8-kb Sph I-Pst I fragment of pFF133 was transferred to the Escherichia coli vector pGEM-3Zf(+) (Promega). The 3.5-kb Kpn I fragment within the region of complementing DNA was replaced with the 1.3-kb BamHI-Xho I HIS3 fragment from plasmid pJJ215 (19) in both orientations (Fig. 1B) . The disruption fragment with HIS3 transcribed in the antisense direction was excised by digestion with Sst I plus Sph I and introduced into diploid strain YFK419. Hybridization analysis confirmed that transformants were heterozygous for the disrupted allele of the cloned DNA (data not shown). The diploid, which was unaltered in its growth rate or sensitivity to FK506, was induced to sporulate and dissected. Of 50 asci, 24 yielded tetrads with four viable spores, and His+ and His-pheno- (6, 12 Some weak hybridization to chromosome VII or XV (unresolved on this blot) was also observed. Southern hybridization analysis of digests of genomic DNA revealed that the FKSJ DNA cloned from GRF88 is colinear with the genome, but the corresponding region of YFK007 (parent of thefksl-l mutant) differs by lacking the Sph I site and having additional Bgl II, Xba I, and Sst I sites (Fig. 2) . These strain differences apparently represent allelic variation at this locus. We also noted in these experiments weakly hybridizing bands which did not derive from the FKS1 locus. Cloning of ETGI. In an independent line of investigation, we cloned the echinocandin target gene (ETGI) by complementation of two different alleles. The plasmid pJAM54, containing an 8.2-kb insert of yeast genomic DNA from strain YFK093 (a derivative of YFK007), was isolated by its ability to partially reverse the EchR phenotype of etgl-l. Subclones of this plasmid failed to complement etgl-l, and the results suggested that the complementing DNA was >6 kb long (data not shown). In a second approach, the plasmid pMS14 was isolated from the GRF88 library by its ability to reverse the Niks phenotype of etgl-4. Restriction and hybridization analysis of pJAM54 and pMS14 indicated that the cloned fragments derived from the same locus. Moreover, pJAM54 complemented the NikS phenotype of etgl-4 to the same extent as pMS14 (data not shown).
To determine whether this locus was linked to etgl-1, a URA3-selectable integration plasmid (20) carrying the 8.2-kb BamHI-Nru I fragment of the cloned DNA from pJAM54 was inserted into the etgl-l mutant. Southern hybridization analysis of two independent Ura+ clones ( Fig. 3A) confirmed that the plasmid had integrated at the locus of the cloned DNA (Fig. 3B) . The integrants were intermediate in resistance to L-733,560 (Ech'), similar to heterozygous etgl-l diploids (data not shown). In a cross to the wild type, EchI and Ura+ cosegregated in 17 of 17 tetrads. All 68 progeny were either EchS or EchI; no Ura+Echs or Ura-EchI segregants were recovered. In a separate experiment, the etgl-l mutation was recovered by allele rescue (21) . pJAM54 lacking the internal 3.5-kb Kpn I fragment was transformed into the etgl-l mutant. Plasmid DNA isolated from drug-resistant transformants conferred resistance to L-733,560 when intro- 5) . The 1.3-kb Sal I-Cla I fragment from pJAM54 was used to prepare the probe. (The location of the corresponding fragment of pFF133 is marked in Fig. 1A.) (B) Schematic representation of a region of the chromosome of R560-1C and an integrant. Cleavage sites for the restriction enzymes used to linearize pJAM56 for integration (Afl II) and digest genomic DNA (Hpa I) are marked, and the direction of transcription is depicted with arrows. The etgl-I locus is shown by the white box, cloned ETGI from pJAM56 is shown in black, and the vector portion of pJAM56, including the URA3 gene, is depicted by the narrow hatched box. The expected 12.5-and 14-kb Hpa I fragments in this region are indicated at the bottom. Short heavy bars show the sites of hybridization of the Sal I-Cla I probe.
duced into JkslAl strains (data not shown). These results firmly established that etgl-l is allelic with the cloned DNA.
A deletion/disruption allele was constructed by replacing a 3-kb Bgl II-Sal I fragment ofthe cloned DNA with the HIS3 fragment from plasmid pJJ215 and introducing the disruption fragment into the diploid strain W303 (6). Disrupted meiotic segregants of this diploid were slow growing. Several disrupted haploids were mated with etgl-l haploids. The resulting diploids were EchR, showing that the deletion/disruption is allelic with etgl-l and that the cloned DNA carries the ETGI gene. The sensitivity of the etglAl ::HIS3 disruption mutant to a variety of antifungal agents was tested. Surprisingly, this analysis revealed that the etglAJ ::HIS3 mutant was as sensitive to FK506 and L-733,560 as thefksl::HIS3 mutants (data not shown).
A comparison of the two clones showed that ETGI and FKSI were the same. (i) The restriction map of the cloned DNA in pJAM54 was identical to that of the FKSJ locus of YFK007, the strain from which it was derived (Fig. 2) Hereafter we use the gene designation FKSJ, since this was used in the first published description of this gene (11) .
Glucan Synthase. Since it seemed likely from these results that FKSJ encoded a subunit of 1,3-/-D-glucan synthase, this enzyme was assayed in membrane fractions from wild-type, JksJAl ::HIS3, and fksl-l strains. A 5-to 8-fold decrease in specific activity was seen in thefkslAll and thefksl-l mutants (Table 1 ). The residual activity of the mutants was 3-fold more sensitive to L-733,560 (Table 1) , reflecting the increased susceptibility of whole cells to drug (Fig. 1E) The specific activity, determined from the rate of accumulation of labeled glucose into the acid precipitate over the time interval of 60-120 min, is the average of six determinations and is given as nmol/min per mg of protein. The IC50 values are the average of two determinations. L-733,560 was added from a 2 mM stock in water, and the amount of product was determined at 90 min. The degree of polymerization (D.P.) is based on gel filtration in 0.15 M NaOH with dextran standards (6) . The sensitivity to laminarinase is expressed as the percent of product digested (6) . The wild type (WT) is YFK007, and the mutants are congenic derivatives. from these mutants showed that the synthesized glucan remained highly polymerized (>2000 glucose units).
Sequence ofFKSI. The 7.7-kb region between the Sph I and Bgl II sites of pFF119 was sequenced. The region encodes a single large ORF with a predicted protein product (Fkslp) of 1876 aa (calculated Mr of 214,849). The location of the ORF coincides closely with the region necessary for complementation of the Jlsl-J mutation (Fig. 1A) . The that even a slight truncation of the C terminus of Fkslp results in the loss of biological activity. The amino acid sequence of Fkslp has no significant similarity to any translated frames in the GenBank/EMBL DNA data bases (June 1, 1994).
Hydropathy analysis (22) predicts that Fkslp is an integral membrane protein with about 16 transmembrane helices (TMHs; Fig. 4 ). The N-terminal hydrophilic domain of Fkslp is 454 aa long and lacks a cleavable signal sequence. Thus, Fkslp resembles the class of membrane proteins for which the first TMH acts as an uncleaved signal sequence which directs the insertion of the nascent polypeptide into the membrane. Such signal-anchor sequences can have either orientation, depending on the difference in the charges of the 15 flanking residues, with the more positive portion usually on the cytosolic side (23) . With this rule the N terminus of Fkslp is predicted to be cytosplasmic. Two large membrane domains were identified. One is centrally located and contains 6 presumed TMHs separated by relatively short hydrophilic regions; the other is more C-terminal and contains 10 TMHs. These two membrane domains are separated by a large hydrophilic domain of 582 aa, which is predicted by this model to be cytoplasmic. (Fig. 5 ).
DISCUSSION
We propose that FKSJ encodes a component of the multisubunit fungal 1,3-3-D-glucan synthase. Our genetic and molecular evidence demonstrates that FKSI is the wild-type allele of the etgl-l (EchR) mutation. This mutation results in echinocandin-resistant glucan synthase activity in membranes isolated from R560-1C (6) . The The high apparent degree of homology between S. cerevisiae FKSJ and DNA fragments from Ca. albicans, A. fumigatus, and Cr. neoformans suggests that similar genes may be found among other fungi. 1,3-,B3D-Glucan is a component of Candida and Aspergillus cell walls, and the in vitro enzyme reactions from these fungi have substrate affinities, susceptibility to echinocandin inhibition, and product profiles similar to the S. cerevisiae glucan synthesis reaction. Whether these genes encode a pneumocandin-sensitive 1,3- ,-D-glucan synthase subunit must await cloning and characterization.
The properties of the JksJ-J and Jksl::HIS3 null alleles suggest some unexpected relationships between the antifungal mechanism of FK506 and CsA and the synthesis of glucan. FK506 suppresses interleukin-2 gene transcription in mammalian T cells (9, 10) and forms a complex, in both yeast and T cells, with a binding protein (FKBP12) that inhibits the activity of the Ca2+/calmodulin-dependent protein phosphatase calcineurin (8) . It is particularly intriguing that Ca2+ can partially reverse the slow-growth defect of Jksl-l cells (8) .
Deposition of chitin in the cell wall may be affected by demonstrated. An elucidation of the defect resulting in nikkomycin Z hypersensitivity may reveal novel relationships in the assembly of these polysaccharides in the cell wall and identify novel targets for antifungal antibiotics.
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